Home
>
US Stocks
>
Arbutus Biopharma Corp
Arbutus Biopharma Corp
ABUS

Arbutus Biopharma Corp

$4.126.15%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
4.1
Today Low/High
4.04 / 4.12
52 Week Low/High
$2.31 / $5.87
P/E ratio
-3.9102
Market Cap
$329.22M

Company Details

Arbutus Biopharma Corporation is a biopharmaceutical company primarily dedicated to discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection. The Company is advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discovery and development effort for treating coronaviruses (including COVID-19).
Organisation
Arbutus Biopharma Corp
Headquaters
Warminster, Pennsylvania, US
Employees
77
Industry
Health Technology
CEO
William Collier

Discover more

Frequently Asked Questions

What is Arbutus Biopharma Corp share price today

Can Indians buy Arbutus Biopharma Corp shares?

How can I buy Arbutus Biopharma Corp shares from India?

Can Fractional shares of Arbutus Biopharma Corp be purchased?

What are the documents required to start investing in Arbutus Biopharma Corp stocks?

We are a SEBI registered investement advisor